Fee-for-Service Pharmacy Provider Notice #315 | September PDL Provider Notice | 11/14/2023 |
Fee-for-Service Pharmacy Provider Notice #314 | Member Eligibility Issue | 10/17/2023 |
Fee-for-Service Pharmacy Provider Notice #313 | Brixadi PDL Addition and Incentive Fee | 10/09/2023 |
Fee-for-Service Pharmacy Provider Notice #312 | Physician Protocol for COVID-19 Test Kits REMINDER | 10/04/2023 |
Fee-for-Service Pharmacy Provider Notice #311 | Synagis | 09/26/2023 |
Fee-for-Service Pharmacy Provider Notice #310 | Opioid Antagonist Provider Protocol and OTC Naloxone Coverage | 09/05/2023 |
Fee-for-Service Pharmacy Provider Notice #309 | FFS Vaccine Coverage Reminder | 08/30/2023 |
Fee-for-Service Pharmacy Provider Notice #308 | PHE Unwinding Medicaid Renewal Reminder | 07/19/2023 |
Fee-for-Service Pharmacy Provider Notice #307 | May 2023 P&T PDL Changes | 07/10/2023 |
Fee-for-Service Pharmacy Provider Notice #306 | Public Health Emergency Unwinding Reminder | 06/21/2023 |
Fee-for-Service Pharmacy Provider Notice #305 | OTC List Changes | 06/09/2023 |
Fee-for-Service Pharmacy Provider Notice #304 | Drug Shortage Bypass Removal | 05/30/2023 |
Fee-for-Service Pharmacy Provider Notice #303 | Akorn Pharmaceuticals Recall | 05/17/2023 |
Fee-for-Service Pharmacy Provider Notice #302 | Insulin Glargine Reminder | 05/15/2023 |
Fee-for-Service Pharmacy Provider Notice #301 | March 2023 PDL Changes | 05/08/2023 |
Fee-for-Service Pharmacy Provider Notice #300 | Makena Market Withdrawal | 04/10/2023 |
Fee-for-Service Pharmacy Provider Notice #299 | Routine PDL Changes | 03/16/2023 |
Fee-for-Service Pharmacy Provider Notice #298 | KASPER System Outage | 03/15/2023 |
Fee-for-Service Pharmacy Provider Notice #297 | Testosterone Pump PDL Change | 03/14/2023 |
Fee-for-Service Pharmacy Provider Notice #296 | Drug Shortage Bypass Reminder | 03/14/2023 |
Fee-for-Service Pharmacy Provider Notice #295 | Paxlovid Protocol No Longer Active | 03/08/2023 |
Fee-for-Service Pharmacy Provider Notice #294 | Drug Shortage Bypass | 02/20/2023 |
Fee-for-Service Pharmacy Provider Notice #293 | Further Extension of Temporary PDL Changes Due to Shortages | 02/08/2023 |
Fee-for-Service Pharmacy Provider Notice #292 | Lidocaine Patch PDL Update | 02/02/2023 |
Fee-for-Service Pharmacy Provider Notice #291 | Further Extension of Temporary PDL Changes Due to Shortages | 01/30/2023 |
Fee-for-Service Pharmacy Provider Notice #290 | Further Extension of Temporary PDL Changes Due to Shortages | 01/12/2023 |
Fee-for-Service Pharmacy Provider Notice #289 | Preferred Drug List (PDL) Changes | 01/11/2023 |
Fee-for-Service Pharmacy Provider Notice #288 | November 2022 P&T PDL Changes | 01/09/2023 |
Fee-for-Service Pharmacy Provider Notice #287 | Temporary PDL Changes Due to Shortages Extended | 01/04/2023 |
Fee-for-Service Pharmacy Provider Notice #286 | Temporary PDL Changes Due to Shortages | 12/31/2022 |
Fee-for-Service Pharmacy Provider Notice #285 | Immune Globulins (IVIG, SCIG) Criteria Change | 12/08/2022 |
Fee-for-Service Pharmacy Provider Notice #284 | Brand/ Generic Insulin Changes | 11/21/2022 |
Fee-for-Service Pharmacy Provider Notice #283 | September 2022 PDL Changes | 11/01/2022 |
Fee-for-Service Pharmacy Provider Notice #282 | Suboxone Incentive Fee Changes | 10/05/2022 |
Fee-for-Service Pharmacy Provider Notice #281 | Synagis Update | 09/22/2022 |
Fee-for-Service Pharmacy Provider Notice #280 | ProAir HFA Discontinuation | 09/20/2022 |
Fee-for-Service Pharmacy Provider Notice #279 | Paxlovid Physician Protocol | 08/16/2022 |
Fee-for-Service Pharmacy Provider Notice #278 | Delivery Requirements | 08/08/2022 |
Fee-for-Service Pharmacy Provider Notice #277 | Naloxone Treatment Physician Protocol | 08/08/2022 |
Fee-for-Service Pharmacy Provider Notice #276 | May 2022 P&T PDL Changes | 07/01/2022 |
Fee-for-Service Pharmacy Provider Notice #275 | Generic Truvada Criteria Removal | 06/06/2022 |
Fee-for-Service Pharmacy Provider Notice #274 | Quantity Limits Added to Disposable Pumps and CGMs | 06/06/2022 |
Fee-for-Service Pharmacy Provider Notice #273 | Lidoderm Shortage Leads to Temporary PDL Changes | 05/06/2022 |
Fee-for-Service Pharmacy Provider Notice #272 | New Omnipod NDCs Added to the Diabetic Supply List | 05/04/2022 |
Fee-for-Service Pharmacy Provider Notice #271 | March 2022 PDL Changes | 05/02/2022 |
Fee-for-Service Pharmacy Provider Notice #270 | MetroCream Shortage | 04/25/2022 |
Fee-for-Service Pharmacy Provider Notice #269 | Injectable Drug List | 04/04/2022 |
Fee-for-Service Pharmacy Provider Notice #268 | Physician Protocol for COVID-19 Test Kits | 02/01/2022 |
Fee-for-Service Pharmacy Provider Notice #267 | COVID-19 Home Test Kits | 01/28/2022 |
Fee-for-Service Pharmacy Provider Notice #266 | Brand/Generic Switches | 01/25/2022 |
Fee-for-Service Pharmacy Provider Notice #265 | Brand/Generic Reversal | 01/14/2022 |
Fee-for-Service Pharmacy Provider Notice #264 | Zoloft Oral Concentrate Update | 01/05/2022 |
Fee-for-Service Pharmacy Provider Notice #263 | November 2021 PDL and OTC List Changes | 01/03/2022 |
Fee-for-Service Pharmacy Provider Notice #262 | Trulicity/Ozempic Switch | 12/21/2021 |
Fee-for-Service Pharmacy Provider Notice #261 | Zoloft Oral Concentrate | 12/16/2021 |
Fee-for-Service Pharmacy Provider Notice #260 | Antidepressants | 12/14/2021 |
Fee-for-Service Pharmacy Provider Notice #259 | Emergency Declaration Early Refill Bypass | 12/13/2021 |
Fee-for-Service Pharmacy Provider Notice #258 | September 2021 PDL and Diabetic Supply List Changes | 11/02/2021 |
Fee-for-Service Pharmacy Provider Notice #257 | May 2021 PDL Changes | 07/01/2021 |
Fee-for-Service Pharmacy Provider Notice #256 | Senate Bill 51 and Support Act | 06/11/2021 |
Fee-for-Service Pharmacy Provider Notice #255 | OTC Drug List Update | 06/01/2021 |
Fee-for-Service Pharmacy Provider Notice #254 | March 2021 PDL Changes | 05/01/2021 |
Fee-for-Service Pharmacy Provider Notice #253 | BD Diabetic Supplies | 03/24/2021 |
Fee-for-Service Pharmacy Provider Notice #252 | COVID-19 Vaccine Updated Fees | 03/23/2021 |
Fee-for-Service Pharmacy Provider Notice #251 | November 2020 PDL Changes | 01/22/2021 |
Fee-for-Service Pharmacy Provider Notice #250 | COVID-19 Vaccine | 01/04/2021 |
Fee-for-Service Pharmacy Provider Notice #249 | Diabetic Supply Changes | 12/01/2020 |
Fee-for-Service Pharmacy Provider Notice #248 | Single PDL Changes | 11/06/2020 |
Fee-for-Service Pharmacy Provider Notice #247 | September 2020 PDL Changes | 11/06/2020 |
Fee-for-Service Pharmacy Provider Notice #246 | NCPDP Quantity Prescribed Update | 09/02/2020 |
Fee-for-Service Pharmacy Provider Notice #245 | May 2020 PDL Changes | 07/23/2020 |
Fee-for-Service Pharmacy Provider Notice #244 | Brand/Generic Switches | 05/07/2020 |
Fee-for-Service Pharmacy Provider Notice #243 | Presumptive Eligible Members | 05/07/2020 |
Fee-for-Service Pharmacy Provider Notice #242 | Reimbursement Error for Brand over Generic Products | 03/26/2020 |
Fee-For-Service Pharmacy Provider Notice #241 | COVID-19 Emergency Signature Log Change | 03/26/2020 |
Fee-for-Service Pharmacy Provider Notice #240 | November 2019 PDL Changes | 01/27/2020 |
Fee-for-Service Pharmacy Provider Notice #239 | 340B Procedures | 12/19/2019 |
Fee-for-Service Pharmacy Provider Notice #238 | September 2019 PDL Changes | 11/07/2019 |
Fee-for-Service Pharmacy Provider Notice #237 | Pharmacy License Update Reminder | 07/19/2019 |
Fee-for-Service Pharmacy Provider Notice #236 | May 2019 PDL Changes | 07/19/2019 |
Fee-for-Service Pharmacy Provider Notice #235 | March 2019 PDL Changes | 05/06/2019 |
Fee-for-Service Pharmacy Provider Notice #234 | Updated Buprenorphine-Naloxone PA Waiver | 03/04/2019 |
Fee-for-Service Pharmacy Provider Notice #233 | November 2018 PDL Changes | 02/06/2019 |
Fee-for-Service Pharmacy Provider Notice #232 | September 2018 PDL Changes | 01/03/2019 |
Fee-for-Service Pharmacy Provider Notice #231 | Buprenorphine PA Waiver | 10/11/2018 |
Fee-for-Service Pharmacy Provider Notice #230 | Opioid Class Criteria Changes | 09/04/2018 |
Fee-for-Service Pharmacy Provider Notice #229 | May 2018 PDL Changes | 09/04/2018 |
Fee-for-Service Pharmacy Provider Notice #228 | Pharmacy License Update Reminder | 09/04/2018 |
Fee-for-Service Pharmacy Provider Notice #227 | Opioid Class Criteria Changes | 06/15/2018 |
Fee-for-Service Pharmacy Provider Notice #226 | March 2018 PDL Changes | 06/15/2018 |
Fee-for-Service Pharmacy Provider Notice #225 | November 2017 PDL Changes | 06/01/2018 |
Fee-for-Service Pharmacy Provider Notice #224 | May 2017 PDL Changes | 06/01/2018 |